Chemours (CC) pre-announcement more 'positive than negative' - BMO Capital
Tweet Send to a Friend
BMO Capital analyst John McNulty reiterated an Outperform rating and $17.00 price target on Chemours (NYSE: CC) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
